In Business

Follow this topic

Bookmark

Record learning outcomes

Pearl Chemist Limited's pre-tax losses increased by nearly £790,000 according to its latest accounts, although its turnover rose by over £13 million.

The pharmacy chain, which had 27 pharmacies mainly in South-West London as of October 31, 2024 but now has 29 branches, posted a loss before tax of £1,078,109 compared with £289,584 in 2023.

Pearl Chemist’s loss for the year ending October 31, 2024 after tax stood at £1,295,035 compared with £730,275 in 2023. It latest accounts also revealed the company paid interim dividends of £336,816 compared with £100,000 in 2023.

Its turnover went from £47,934,975 in 2023 to £61,161,560 last year while its gross profit increased from £11,942,970 in 2023 to £13,730,471 in 2024. Its operating profit, however, fell from £365,220 to £40,936 during the same period.

Pearl Chemist said it had a “high proportion of recurring customers”, with repeat prescriptions accounting for about 70 per cent of its dispensing activities which made up 2,797,251 items, a 23.1 per cent increase on 2023.

The accounts also showed the “combined consideration” for the two recently acquired pharmacies was £3,430,000 while Pearl Chemist also purchased freehold land for of £1,200,000 on July 1, 2025.

Its directors said they remained “optimistic about the company’s future” and insisted it is “well positioned to build on its success and deliver sustained value to patients” over the coming years.